GLAXOSMITHKLINE PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of GlaxoSmithKline Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.64₹ 16.55
As on Dec 16, 2025, 1:19 PM IST
GlaxoSmithKline Pharmaceuticals Price Performance
Today's LowToday's High
₹2,573.30₹2,591.60
₹2,591.60
52 Weeks' Low52 Weeks' High
₹1,924.30₹3,515.95
₹2,591.60
Open Price
₹2,580.40
Prev. Close
₹2,575.05
Volume
856
Over the last 5 years, the share price of GlaxoSmithKline Pharmaceuticals has gained 10.79% CAGR. Over the past year, the corresponding return has been 13.65%.
GlaxoSmithKline Pharmaceuticals’s current P/E of 45.74x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
GlaxoSmithKline Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | 0.61 | 3.39 | -5.95 | -23.49 | 13.02 | 24.24 | 10.66 |
| Sun Pharmaceutical Industries | 0.63 | 1.34 | 10.96 | 6.04 | -1.26 | 21.63 | 25.40 |
| Divi's Laboratories | 0.32 | -3.23 | 3.58 | -5.63 | 7.86 | 23.77 | 11.12 |
| Torrent Pharmaceuticals | 0.05 | -1.36 | 6.54 | 14.84 | 12.03 | 33.04 | 21.98 |
| Cipla | 1.00 | -1.99 | -3.38 | -1.39 | 3.96 | 11.34 | 13.84 |
| Dr. Reddy's Laboratories | 2.31 | 2.45 | -2.71 | -5.33 | 0.40 | 13.95 | 4.82 |
| Lupin | 1.91 | 1.93 | 1.95 | 4.01 | 1.40 | 42.00 | 16.80 |
| Zydus Lifesciences | 0.14 | -1.40 | -11.00 | -5.42 | -6.76 | 31.17 | 14.43 |
| Mankind Pharma | -2.25 | -5.11 | -17.09 | -10.05 | -20.84 | 14.36 | 8.39 |
| Aurobindo Pharma | 1.20 | -4.96 | 7.68 | 2.79 | -5.56 | 38.60 | 6.07 |
| Alkem Laboratories | -0.48 | -1.49 | 2.36 | 15.83 | 3.61 | 22.67 | 14.21 |
| Abbott India | -1.12 | -6.07 | -10.21 | -12.17 | -1.60 | 10.49 | 11.35 |
| Glenmark Pharmaceuticals | 1.61 | 5.57 | -5.18 | 17.05 | 26.95 | 67.69 | 30.29 |
| Laurus Labs | -2.69 | -2.77 | 11.04 | 46.20 | 73.31 | 36.78 | 24.01 |
| Biocon | 0.60 | -8.41 | 7.15 | 7.99 | 9.11 | 13.19 | -3.46 |
| Anthem Biosciences | 2.07 | 0.98 | -19.12 | -8.00 | -8.00 | -2.74 | -1.65 |
| Ipca Laboratories | -0.89 | -1.72 | 9.80 | 5.56 | -8.12 | 18.99 | 5.08 |
| Ajanta Pharma | -0.62 | 3.98 | 1.98 | 0.26 | -10.17 | 29.92 | 18.22 |
| J B Chemicals & Pharmaceuticals | -0.79 | -2.17 | 5.94 | 2.76 | -2.21 | 18.93 | 26.85 |
| Gland Pharma | -1.81 | -7.35 | -16.83 | -4.97 | -2.90 | -0.27 | -5.24 |
Over the last one year, GlaxoSmithKline Pharmaceuticals has gained 13.02% compared to peers like Sun Pharmaceutical Industries (-1.26%), Divi's Laboratories (7.86%), Torrent Pharmaceuticals (12.03%). From a 5 year perspective, GlaxoSmithKline Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (25.40%) and Divi's Laboratories (11.12%).
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,583.36 | 2,582.12 |
| 10 | 2,550.05 | 2,566 |
| 20 | 2,527 | 2,556.93 |
| 50 | 2,613.93 | 2,607.99 |
| 100 | 2,722.88 | 2,693.35 |
| 200 | 2,851.39 | 2,718.06 |
GlaxoSmithKline Pharmaceuticals Share Holding Pattern
In the latest quarter, GlaxoSmithKline Pharmaceuticals saw a rise in promoter holding to 150.00%, while DII stake increased to 8.00%, FII holding rose to 5.00%, and public shareholding moved down to 12.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
GlaxoSmithKline Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 12,00,000 | 1.32 | 308.34 | |
| 11,00,000 | 0.94 | 282.65 | |
| 9,13,226 | 2.77 | 234.65 | |
| 5,59,000 | 0.34 | 143.64 | |
| 3,99,331 | 0.18 | 102.61 | |
| 3,33,621 | 0.55 | 85.72 | |
| 2,60,835 | 1.85 | 67.02 | |
| 2,30,000 | 0.81 | 59.1 | |
| 2,27,787 | 0.86 | 58.53 | |
| 1,82,918 | 1.11 | 47 |
* Excluding Index & Arbitrage Funds
GlaxoSmithKline Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 13, 2025, 2:04 AM IST | GlaxoSmithKline Phar - Disclosure Under Regulation 30 |
| Nov 20, 2025, 1:49 AM IST | GlaxoSmithKline Phar - Disclosure Under Regulation 30 |
| Nov 10, 2025, 6:35 PM IST | GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 07, 2025, 3:08 AM IST | GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 06, 2025, 10:19 PM IST | GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 3723.49 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressGSK House, Dr. Annie Besant Road, Mumbai Maharashtra 400030
- Contact
Management
- Ms. R S KarnadChairperson
- Mr. B AkshikarManaging Director
- Mr. J ChandyWholeTime Director & CFO
- Mr. S WilliamsNon Executive Director
- Mr. M AnandIndependent Director
- Mr. P R SomasundaramIndependent Director
- Dr. A WadhawanIndependent Director
- Dr.(Ms.) S MaheshwariIndependent Director
FAQs on GlaxoSmithKline Pharmaceuticals Share Price
What is the share price of GlaxoSmithKline Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for GlaxoSmithKline Pharmaceuticals is ₹2,591.60 as on Dec 16, 2025.
What kind of stock is GlaxoSmithKline Pharmaceuticals?
The GlaxoSmithKline Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of GlaxoSmithKline Pharmaceuticals?
The market cap of GlaxoSmithKline Pharmaceuticals is ₹43,688.97 Cr as on Dec 16, 2025.
What are today's High and Low prices of GlaxoSmithKline Pharmaceuticals?
Today’s highest and lowest price of GlaxoSmithKline Pharmaceuticals are ₹2,591.60 and ₹2,573.30.
What are the 52 Week High and 52 Week Low of GlaxoSmithKline Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which GlaxoSmithKline Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of GlaxoSmithKline Pharmaceuticals is ₹3,515.95 and 52-week low of GlaxoSmithKline Pharmaceuticals is ₹1,924.30 as on Dec 16, 2025.
How has the GlaxoSmithKline Pharmaceuticals performed historically in terms of returns?
The GlaxoSmithKline Pharmaceuticals has shown returns of 0.58% over the past day, 3.97% for the past month, -5.42% over 3 months, 13.65% over 1 year, 24.48% across 3 years, and 10.79% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of GlaxoSmithKline Pharmaceuticals?
P/E ratio of and PB ratio of GlaxoSmithKline Pharmaceuticals are 45.74 and 22.39 on Dec 16, 2025. While the company gives a dividend yield of 2.09 per annum.
GlaxoSmithKline Pharmaceuticals News
✕
Market Pulse